Evaluation of Clinical, Perceived and Instrumental Efficacy of a Scar Gel in Preventing Hypertrop… (NCT06751433) | Clinical Trial Compass
RecruitingPhase 1/2
Evaluation of Clinical, Perceived and Instrumental Efficacy of a Scar Gel in Preventing Hypertrophic Scars
Brazil80 participantsStarted 2025-04-03
Plain-language summary
Evaluation of the safety and topical efficacy of a scar gel after 90 days of continuous use, comparing it to a benchmark for preventing hypertrophic scars and improving appearance, hydration and pigmentation.
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Participants of both sexes aged between 18 and 70 years;
✓. Participants with recent scars (\<30 days);
✓. Participants with phototypes III to VI according to the Fitzpatrick scale;
✓. Agree to follow the trial procedures and attend the center on the days and times determined for evaluations;
✓. Understand, agree to and sign the free and informed consent form.
✓. Types of scars: cesarean section, breast implant or blunt cut injury.
Exclusion criteria
✕. Pregnancy or risk of pregnancy;
✕. History of atopic or allergic reactions to cosmetic products;
✕. Participants who are using topical antibiotics or other skin products on the same area being evaluated;
✕. Immunosuppression due to drugs or active diseases;
✕. Decompensated endocrine diseases;
✕. Relevant clinical history or current evidence of alcohol or other drug abuse;
✕. Known history or suspected intolerance to products in the same category;